567.4MSEK
Type
Common Stock
Exchange
LSE
Currency Code
SEK
Currency Name
Swedish krone
Country Name
UK
Country ISO
GB
ISIN
SE0014401378
CUSIP
-
Sector
Healthcare
Industry
Biotechnology & Medical Research
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
0.32
PEG Ratio
-
Book Value
41.99
Dividend Share
0.75
Dividend Yield
0.42%
Earnings Share
5.868
Wall Street Target Price
-
EPS Estimate Current Year
-
EPS Estimate Next Year
-
EPS Estimate Current Quarter
0
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Revenue TTM
10,417,999,872
Gross Profit TTM
3,915,000,064
EBITDA
1,363,000,064
Profit Margin
2.97%
Return On Assets TTM
3.79%
Return On Equity TTM
6.05%
Revenue Per Share TTM
85.488
Qtly Revenue Growth YOY
5.10%
Diluted Eps TTM
5.868
Qtly Earnings Growth YOY
91.90%
Trailing PE
0.32
Forward PE
0
Price Sales TTM
0.5061
Price Book MRQ
0
Enterprise Value Revenue
0
Enterprise Value EBITDA
0
2.41
0.73%15.55
-7.99%2.10
-5.61%